6-Bromo-<em>N</em>-(3-(difluoromethyl)phenyl)quinolin-4-amine
A routine synthesis was performed to furnish the title compound which incorporates a versatile difluoromethyl group on the aniline substitution of a 4-anilinoquinoline kinase inhibitor motif. In addition, the small molecule crystal structure (of the HCl salt) was solved, which uncovered that the dif...
Main Authors: | Christopher R. M. Asquith, Graham J. Tizzard |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Molbank |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-8599/2020/4/M1161 |
Similar Items
-
New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I–Interacting Kinase (TNNi3K)
by: Christopher R. M. Asquith, et al.
Published: (2020-04-01) -
Emergency Online Language Education and Academic Integrity
by: Salim Razı, et al.
Published: (2021-06-01) -
Structure–Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017–Present)
by: Alexandru Șandor, et al.
Published: (2023-04-01) -
Antiproliferative Efficacy of <i>N</i>-(3-chloro-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine, DW-8, in Colon Cancer Cells Is Mediated by Intrinsic Apoptosis
by: Rabin Neupane, et al.
Published: (2021-07-01) -
Prevalence and risk factors for allergic sensitization: 3 cross-sectional studies among schoolchildren from 1996 to 2017
by: Eva Rönmark, PhD, et al.
Published: (2023-11-01)